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LETTER TO THE EDITOR
Clinical comparison of patients 
with benign urachal masses versus urachal 
carcinomas
Xing Bi1†, Zhiming Wu2†, Hui Han2* and Fangjian Zhou2*
Abstract 
The clinical features of 17 patients with benign urachal masses and 30 patients with urachal carcinoma treated at 
Sun Yat-sen University Cancer Center were analyzed retrospectively. Univariate analysis indicated that seven param-
eters differed significantly between the two groups. Binary logistic regression analyses showed that the rate of gross 
hematuria was significantly higher (P = 0.042, Exp[B] = 7.889) and the rate of fatty infiltration of the Retzius space was 
significantly lower (P = 0.006, Exp[B] = 0.028) in patients with urachal carcinoma than in those with benign urachal 
masses. Gross hematuria and fatty infiltration of the Retzius space may be indications of malignant and benign ura-
chal masses, respectively.
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Background
Urachal masses may be malignant or benign, and the 
accuracy of preoperative diagnosis is poor [1–3]. In the 
present study, we retrospectively analyzed the clinical 
features of patients with both types of disease to identify 
indicators for accurate preoperative diagnosis to poten-
tially prevent unnecessary resection.
Patients and methods
Clinical data of patients with urachal masses treated 
between 2000 and 2015 at Sun Yat-sen University Can-
cer Center were retrospectively analyzed. Patients were 
included if they (1) were aged >18  years, (2) had been 
diagnosed based on pathology, and (3) had lesions 
located in the dome or midline of the bladder. Addition-
ally, patients with urachal carcinoma were included if (1) 
there was a sharp demarcation between the tumor and 
the bladder urothelium and (2) the patient did not have a 
primary adenocarcinoma of another organ [4].
All patients provided a detailed medical history. The 
parameters recorded included patient age, sex, the white 
blood cell count, the percentage of neutrophils, and the 
presence of gross hematuria, lower urinary tract symp-
toms (frequency, urgency, and dysuria), a palpable mass, 
lower abdominal pain (complaints of pain and tender-
ness), mucinuria, and calcification. Fatty infiltration of 
the Retzius space was characterized by enhanced patches 
or strips in the Retzius space, with vague indications of 
fat surrounding the lesion. Diffuse thickening of the adja-
cent bladder wall was characterized by thickening of the 
bladder wall not only around the lesions but also across 
the whole bladder dome and two side walls, with the 
peripheral wall gradually thinning to normal. Fatty infil-
tration and bladder wall thickening were examined using 
computed tomography (CT). All images were evaluated 
by two radiologists using the above criteria, with consist-
ent results.
Continuous data were compared using independent-
sample t test, and categorical data were compared using 
Chi square test. Factors differing significantly between 
patients with benign urachal masses and those with ura-
chal carcinoma in the univariate analysis were further 
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subjected to binary logistic regression analysis (likeli-
hood ratio test). A P value <0.05 was considered statisti-
cally significant.
Results
The study included 30 patients with urachal carcinoma 
(the malignant group) and 17 with benign urachal masses 
(the benign group). The baseline patient characteristics 
are shown in Table 1. The median age was 45 years (range 
22–62 years) in the malignant group and 41 years (range 
18–75 years) in the benign group (P = 0.362). The malig-
nant group was composed of 21 (70%) men and 9 (30%) 
women, whereas the benign group was composed of 7 
(41%) men and 10 (59%) women.
Of the 30 patients with urachal carcinoma, 29 had 
adenocarcinomas, and 1 had a sarcomatoid carcinoma 
combined with adenocarcinoma. Of the 17 patients with 
benign urachal masses, 15 had infected urachal cysts 
with chronic inflammation, and 2 had xanthogranuloma. 
Imaging indices are presented in Fig. 1.
Table 1 shows the univariate analysis of all 12 parame-
ters compared between the malignant and benign groups. 
No significant differences were observed in age, sex, the 
presence of a palpable mass, mucinuria, or calcification. 
The rate of gross hematuria was higher in the malignant 
group than in the benign group (P = 0.021). In contrast, 
the rates of lower urinary tract symptoms (P  =  0.011), 
lower abdominal pain (P = 0.004), fatty infiltration of the 
Retzius space (P  <  0.001), and diffuse thickening of the 
adjacent bladder wall (P < 0.001) as well as the percentage 
of neutrophils (P = 0.004) and the white blood cell count 
(P = 0.001) were significantly higher in the benign group 
than in the malignant group.
Binary logistic regression analysis of the seven 
parameters that differed significantly between the two 
groups in the univariate analysis showed that the rate 
of gross hematuria was significantly higher (P  =  0.042, 
Exp[B]  =  7.889) and the rate of fatty infiltration of 
the Retzius space was significantly lower (P  =  0.006, 
Exp[B]  =  0.028) in the malignant group than in the 
benign group.
Discussion
Urachal carcinoma is a rare but highly malignant epithe-
lial cancer that is difficult to distinguish from a benign 
urachal mass [5]. Urachal inflammation and certain 
benign urachal neoplasms, including adenomas, fibro-
mas, villous adenomas, and mucinous cystadenomas, can 
form masses.
Urachal carcinoma has been reported more frequently 
in men than in women (1.49:1), and most patients are 
older than 50 years [6, 7]. However, in the present study, 
the median age of the patients with urachal carcinoma 
was 45 years, with no significant differences between the 
two groups in terms of age or sex.
Multivariate analysis identified two parameters 
that differed significantly between the benign and 
the malignant groups. Gross hematuria was signifi-
cantly associated with urachal carcinoma (P = 0.042), 
Table 1 Univariate analysis of all 12 parameters compared 
between  patients with  benign urachal masses and  those 
with urachal carcinoma







 Male 7 21
 Female 10 9
Gross hematuria 0.021
 Present 6 21
 Absent 11 9
Lower urinary tract 
symptoms
0.011
 Present 8 4
 Absent 9 26
Palpable mass 0.632
 Present 1 3




 Present 8 3
 Absent 9 27
Mucinuria 0.283
 Present 0 2
 Absent 17 28
White blood cell 
count
0.001
 ≥10 × 109/L 7 0




 ≥70 9 3
 <70 8 27
Calcification 0.449
 Present 6 14
 Absent 11 16
Fatty infiltration of 
the Retzius space
<0.001
 Present 12 1





 Present 9 0
 Absent 8 30
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whereas fatty infiltration of the Retzius space was 
significantly associated with benign urachal masses 
(P =  0.006). These results were consistent with those 
of previous reports, in which hematuria was a com-
mon risk factor for malignancy [8, 9]. Fatty infiltration 
of the Retzius space has also been reported to be an 
important indirect sign of inflammation in patients 
with urachal cysts [10].
This study had several limitations, including its ret-
rospective nature and the small number of patients. In 
addition, all of the benign urachal masses were inflamed. 
Thus, these results may not apply to all types of benign 
neoplasms.
Conclusions
This study showed that gross hematuria was significantly 
associated with urachal carcinoma, whereas fatty infiltra-
tion of the Retzius space was significantly associated with 
benign urachal masses. Additional studies are needed to 
verify these findings.
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Fig. 1 Computed tomography (CT) manifestations of a urachal carcinoma and a benign urachal mass. a On an axial view of a urachal carcinoma, 
the red arrow indicates the Retzius space without fat infiltration, and the yellow arrow indicates a lack of thickening of the surrounding bladder wall. 
b On an axial view of a urachal carcinoma, the red arrow indicates the Retzius space without fat infiltration, and the yellow arrow indicates calcifica-
tion in central lesions. c On an axial view of a benign urachal mass, the red arrow indicates fatty infiltration of the Retzius space, characterized by 
enhancements of some patches or strips and vague indications of fat surrounding the lesions, and the yellow arrow indicates diffuse thickening of 
the bladder wall not only around the lesions but also across the whole bladder dome and two side walls, with the peripheral wall gradually thinning 
to normal
